MedPath
NMPA Approval

Ondansetron Hydrochloride Injection

国药准字H20056409

June 15, 2020

Drug Information

盐酸昂丹司琼注射液

注射剂

2ml:4mg(按昂丹司琼计)

化学药品

June 15, 2020

Company Information

Applicant Company

Manufacturing Company

盘锦经济开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸昂丹司琼注射液 - NMPA 批准文号 | MedPath